Juicy Fruit, a cannabis hybrid bred from Afghani Indica and Thai Sativa, is notable in plant genetics and clinical research for a near-balanced chemical profile. Its reported genetic split of 55 percent Sativa to 45 percent Indica, together with a THC peak of 26 percent and about 1 percent CBD, places it among the more potent cultivars in its class. The available data describe a cultivar valued for both physical relaxation and mood elevation, though its quality may vary across informal supply channels.
Genetic composition and biochemical profile
The cultivar’s genetic ratio is listed as 55 percent Sativa and 45 percent Indica, an almost even distribution that is described as the basis for its dual physical and cerebral effects. In biochemical terms, the variety reaches a THC peak of 26 percent, a level associated with strong sensory and psychoactive intensity. Its CBD content is approximately 1 percent, a comparatively low share that may still be relevant for some clinical applications.
The flavor profile is characterized by fruit, lemon, piña colada, and plum notes. The available data present Juicy Fruit as a hybrid with a distinct chemotype rather than a uniform pharmacological profile.
|
Metric
|
Data or description
|
|
Sativa-Indica ratio
|
55:45
|
|
THC peak
|
26%
|
|
CBD content
|
About 1%
|
|
Core flavor notes
|
Fruit, lemon, piña colada, plum
|
Clinical use and pharmacological feedback
Clinical feedback summarized in the available data points to a primary mechanism of neurotransmitter balance, producing pronounced euphoria. The effects are described as bidirectional: Indica genetics are linked to physical muscle relaxation, while Sativa genetics are associated with cognitive and mood elevation. Patients have reported frequent use for anxiety, mood disorders, depression, appetite loss, and chronic pain.
The presence of about 1 percent CBD, though limited, is described as potentially useful for some patients as an adjunct to symptom management, including certain seizure-related conditions. That low concentration is not presented as a substitute for high-dose CBD treatment.
Side effects and regional distribution
Reported adverse effects are concentrated in dry mouth and red eyes, common physiological responses among cannabis cultivars. No large-scale data on serious adverse events are presented. Geographically, the cultivar is described as having strong market penetration on the West Coast of North America and in Colorado, where it is a popular regional medical variety.
The available information also notes that informal distribution channels may affect quality stability, potentially causing variation in the product’s consistency and profile.
Frequently Asked Questions
What does the 26 percent THC level mean for first-time users?
A 26 percent THC level falls in the high-concentration range and is associated with strong physical and psychological effects. For users without tolerance, a cautious approach would begin with a very small dose to assess individual response to the potent euphoric and physical effects.
Does the 1 percent CBD content have clinical significance?
The CBD concentration is relatively low, but it may still provide adjunct modulation for some CBD-sensitive patients, particularly in certain seizure-related symptoms or as an auxiliary pain-management measure. It is not sufficient as a replacement for high-dose CBD therapy.
How does the 55:45 genetic ratio affect the experience?
The ratio suggests that users may experience Sativa-associated cognitive lift and mood improvement alongside Indica-linked physical relaxation and muscle relief. That balance may make the cultivar suitable for both daytime and evening use, though individual responses vary with metabolism and tolerance.
Mesajınız 20-3.000 karakter arasında olmalıdır!
Turkish
